AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32912615 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 35944566 — intervention group
Group type: EXPERIMENTAL
Intervention: IPACK block
Number of subjects: 96
Study 35944566 — intervention group
Group type: COMPARATOR
Intervention: No block (Control)
Number of subjects: 96
Study 33510284 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram based on independent predictors (body mass index, serum albumin level, hypertension, number of total dissected axillary lymph nodes, ratio of positive axillary lymph nodes)
Number of subjects: 972
Study 33510284 — intervention group
Group type: EXPERIMENTAL
Intervention: Training cohort
Number of subjects: 972
Study 33510284 — intervention group
Group type: EXPERIMENTAL
Intervention: Validation cohort
Number of subjects: 972
Study 32579779 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative ultrasound guided parasternal block with 0.25% bupivacaine (4 mL into anterior intercostal spaces)
Number of subjects: 90
Study 32579779 — intervention group
Group type: COMPARATOR
Intervention: Postoperative parasternal intercostal block with 0.25% bupivacaine (4 mL into anterior intercostal spaces)
Number of subjects: 90
Study 32579779 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative ultrasound guided parasternal block
Number of subjects: 90
Study 32579779 — intervention group
Group type: COMPARATOR
Intervention: Postoperative parasternal intercostal block
Number of subjects: 90
Study 35760338 — intervention group
Group type: EXPERIMENTAL
Intervention: CPT‐SMART (Cognitive Processing Therapy for PTSD, smoking cessation counseling, pharmacotherapy, and contingency management)
Number of subjects: 120
Study 35760338 — intervention group
Group type: COMPARATOR
Intervention: Yoked comparison group (monetary reinforcement matched to the participant)
Number of subjects: 120
Study 33687692 — intervention group
Group type: EXPERIMENTAL
Intervention: Crisis checklists
Number of subjects: 24
Study 33687692 — intervention group
Group type: COMPARATOR
Intervention: No checklist
Number of subjects: 24
Study 32417119 — intervention group
Group type: EXPERIMENTAL
Intervention: GL+CBI (capacity-building intervention)
Number of subjects: 51
Study 32417119 — intervention group
Group type: COMPARATOR
Intervention: GL-ONLY (comparison group)
Number of subjects: 51
Study 32417119 — intervention group
Group type: COMPARATOR
Intervention: NO-GL (no guidelines)
Number of subjects: 51
Study 35598084 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mL 0.2% Ropivacaine with dexamethasone 8 mg (Group R + D)
Number of subjects: 64
Study 35598084 — intervention group
Group type: COMPARATOR
Intervention: 20 mL 0.2% Ropivacaine (Group R)
Number of subjects: 64
Study 35598084 — intervention group
Group type: EXPERIMENTAL
Intervention: Group R + D
Number of subjects: 64
Study 35598084 — intervention group
Group type: COMPARATOR
Intervention: Group R
Number of subjects: 64
Study 33721441 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimotuzumab + PF induction chemotherapy (NPF group)
Number of subjects: 126
Study 33721441 — intervention group
Group type: COMPARATOR
Intervention: TPF induction chemotherapy (TPF group)
Number of subjects: 126
Study 33672151 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoke-free contract implementation
Number of subjects: 2015
Study 33672151 — intervention group
Group type: EXPERIMENTAL
Intervention: Social gradient effect among girls
Number of subjects: 2015
Study 33672151 — intervention group
Group type: EXPERIMENTAL
Intervention: Odds of boys having a smoke-free contract
Number of subjects: 2015
Study 33940983 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile produce market program (Food on the Move) with SNAP incentive program
Number of subjects: 0
Study 33940983 — intervention group
Group type: COMPARATOR
Intervention: Fresh to You mobile market program
Number of subjects: 0
Study 33940983 — intervention group
Group type: COMPARATOR
Intervention: Live Well, Viva Bien mobile market program
Number of subjects: 0
Study 33727509 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal nitroglycerin patch (10 mg over 24 h, with a second patch after 1 h if contractions persisted)
Number of subjects: 50
Study 33727509 — intervention group
Group type: COMPARATOR
Intervention: Oral nifedipine (20 mg loading dose, followed by 10 mg thrice daily if contractions suppressed)
Number of subjects: 50
Study 33727509 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal nitroglycerin patch
Number of subjects: 50
Study 33727509 — intervention group
Group type: COMPARATOR
Intervention: Oral nifedipine
Number of subjects: 50
Study 32898095 — intervention group
Group type: EXPERIMENTAL
Intervention: FineVision POD F IOL
Number of subjects: 45
Study 32898095 — intervention group
Group type: EXPERIMENTAL
Intervention: RayOne Trifocal IOL
Number of subjects: 45
Study 32898095 — intervention group
Group type: EXPERIMENTAL
Intervention: AcrySof IQ PanOptix IOL
Number of subjects: 45
Study 32898095 — intervention group
Group type: COMPARATOR
Intervention: All IOLs (combined)
Number of subjects: 45
Study 35662230 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression therapy (not specified dosage or duration)
Number of subjects: 58
Study 35662230 — intervention group
Group type: COMPARATOR
Intervention: Standard care (not specified)
Number of subjects: 58
Study 33069653 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter mitral valve repair (TMVr)
Number of subjects: 141
Study 33069653 — intervention group
Group type: EXPERIMENTAL
Intervention: Successful TMVr
Number of subjects: 141
Study 33120078 — intervention group
Group type: EXPERIMENTAL
Intervention: Compound 34 (naphthyridinone scaffold)
Number of subjects: 1
Study 35167198 — intervention group
Group type: EXPERIMENTAL
Intervention: Hexetidine (0.1% w/v)
Number of subjects: 66
Study 35167198 — intervention group
Group type: EXPERIMENTAL
Intervention: H2O2 (1.5%)
Number of subjects: 66
Study 35167198 — intervention group
Group type: COMPARATOR
Intervention: Placebo-control (de-mineralized sterile water)
Number of subjects: 66
Study 35167198 — intervention group
Group type: EXPERIMENTAL
Intervention: Thymol (0.063% w/v)
Number of subjects: 66
Study 34334383 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomics signature (RS) > 0.61
Number of subjects: 77
Study 34334383 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomics nomogram
Number of subjects: 77
Study 32138765 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D/calcium milk fortification and periodontal therapy
Number of subjects: 70
Study 35136981 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 54
Study 35136981 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 34003122 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care with classical music intervention before and during the biopsy procedure
Number of subjects: 64
Study 34003122 — intervention group
Group type: COMPARATOR
Intervention: Standard care only
Number of subjects: 64
Study 35649707 — intervention group
Group type: EXPERIMENTAL
Intervention: HEAVY (high-load strengthening exercise, supervised twice/week)
Number of subjects: 100
Study 35649707 — intervention group
Group type: COMPARATOR
Intervention: LIGHT (low-load strengthening exercise, supervised three times/week)
Number of subjects: 100
Study 35649707 — intervention group
Group type: EXPERIMENTAL
Intervention: HEAVY
Number of subjects: 100
Study 35649707 — intervention group
Group type: COMPARATOR
Intervention: LIGHT
Number of subjects: 100
Study 34914446 — intervention group
Group type: EXPERIMENTAL
Intervention: Tuning in to Kids (TIK) parenting program, 6-week intervention
Number of subjects: 104
Study 34914446 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group (no intervention initially)
Number of subjects: 104
Study 33249347 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment group received constant TENS over the hamstring muscles during exercises.
Number of subjects: 19
Study 33249347 — intervention group
Group type: COMPARATOR
Intervention: Sham group was exposed to a brief TENS current.
Number of subjects: 19
Study 33107921 — intervention group
Group type: EXPERIMENTAL
Intervention: Real electroacupuncture
Number of subjects: 121
Study 33107921 — intervention group
Group type: COMPARATOR
Intervention: Sham electroacupuncture
Number of subjects: 121
Study 35219521 — intervention group
Group type: EXPERIMENTAL
Intervention: High tidal volume (HTV) ventilation (>10 mL/kg predicted body weight)
Number of subjects: 780
Study 35219521 — intervention group
Group type: COMPARATOR
Intervention: Non-high tidal volume (non-HTV) ventilation (≤10 mL/kg predicted body weight)
Number of subjects: 780
Study 32564493 — intervention group
Group type: EXPERIMENTAL
Intervention: Quilting suture
Number of subjects: 140
Study 32564493 — intervention group
Group type: COMPARATOR
Intervention: Conventional closure
Number of subjects: 140
Study 33514490 — intervention group
Group type: EXPERIMENTAL
Intervention: DAPT
Number of subjects: 1086
Study 33514490 — intervention group
Group type: COMPARATOR
Intervention: SAPT
Number of subjects: 1086
Study 33449481 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrile gloves and mask
Number of subjects: 34
Study 33449481 — intervention group
Group type: COMPARATOR
Intervention: Surgical mask
Number of subjects: 34
Study 32228343 — intervention group
Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA) 500 mg/day for 6 months after LSG
Number of subjects: 280
Study 32228343 — intervention group
Group type: COMPARATOR
Intervention: No UDCA treatment (pre-2015 protocol)
Number of subjects: 280
Study 33790084 — intervention group
Group type: EXPERIMENTAL
Intervention: Foam from SM‐4
Number of subjects: 0
Study 33790084 — intervention group
Group type: EXPERIMENTAL
Intervention: Foams from 4% and 1% SM‐4
Number of subjects: 0
Study 33790084 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-containing foam formulations (benzydamine, dexamethasone, allopurinol, rebamipide) prepared with 1–4% SM‐4
Number of subjects: 0
Study 33269838 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of 'kidney three-needle' therapy and fire needling therapy
Number of subjects: 60
Study 33269838 — intervention group
Group type: COMPARATOR
Intervention: Common acupuncture
Number of subjects: 60
Study 35987694 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed face shields with surgical face masks
Number of subjects: 316
Study 35987694 — intervention group
Group type: COMPARATOR
Intervention: Surgical face masks alone (active control)
Number of subjects: 316
Study 34464490 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual cognitive behavioral therapy (CBT)
Number of subjects: 254
Study 34464490 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT with parent involvement
Number of subjects: 254
Study 34464490 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent psychological control
Number of subjects: 254
Study 34464490 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 254
Study 32072597 — intervention group
Group type: EXPERIMENTAL
Intervention: Masking in pragmatic randomized clinical trials (pRCTs)
Number of subjects: 0
Study 32072597 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 33397386 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Advisors (PAs) integrated into clinical oncology teams
Number of subjects: 0
Study 33397386 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 32810574 — intervention group
Group type: EXPERIMENTAL
Intervention: Menu with sustainability labels indicating environmental impact
Number of subjects: 0
Study 32810574 — intervention group
Group type: COMPARATOR
Intervention: Menu without sustainability labels
Number of subjects: 0
Study 32810574 — intervention group
Group type: EXPERIMENTAL
Intervention: Veggie burger labeled as especially sustainable
Number of subjects: 0
Study 32810574 — intervention group
Group type: EXPERIMENTAL
Intervention: Veggie burger labeled as especially tasty
Number of subjects: 0
Study 32810574 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustainability and taste manipulations
Number of subjects: 0
Study 35358738 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose oxytocin
Number of subjects: 140
Study 35358738 — intervention group
Group type: COMPARATOR
Intervention: Low-dose oxytocin
Number of subjects: 140
Study 32203569 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated collaborative care intervention for 12 months
Number of subjects: 409
Study 32203569 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 409
Study 32203569 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated collaborative care intervention
Number of subjects: 409
Study 32651141 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75 g ZM in 10 mL oxymel
Number of subjects: 3
Study 32651141 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 g ZM in 10 mL oxymel
Number of subjects: 3
Study 32651141 — intervention group
Group type: COMPARATOR
Intervention: 10 mL of oxymel
Number of subjects: 3
Study 35365594 — intervention group
Group type: EXPERIMENTAL
Intervention: MK-7 (200 mcg/day)
Number of subjects: 60
Study 35365594 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 33974018 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial therapy (co-trimoxazole or doxycycline)
Number of subjects: 513
Study 33974018 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 513
Study 33974018 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-trimoxazole
Number of subjects: 513
Study 33974018 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline
Number of subjects: 513
Study 33974018 — intervention group
Group type: EXPERIMENTAL
Intervention: Serious adverse events (respiratory events)
Number of subjects: 513
Study 33974018 — intervention group
Group type: EXPERIMENTAL
Intervention: Serious adverse events (infections)
Number of subjects: 513
Study 33974018 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events of special interest (diarrhea)
Number of subjects: 513
Study 33974018 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events of special interest (rash)
Number of subjects: 513
Study 35500958 — intervention group
Group type: EXPERIMENTAL
Intervention: Mulligan traction straight leg raise (TSLR) technique
Number of subjects: 22
Study 35500958 — intervention group
Group type: COMPARATOR
Intervention: Static stretching
Number of subjects: 22
Study 34029448 — intervention group
Group type: EXPERIMENTAL
Intervention: High Dose (HD) glucagon infusion (25 ng/kg/min)
Number of subjects: 31
Study 34029448 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Dose (LD) glucagon infusion (12.5 ng/kg/min)
Number of subjects: 31
Study 34029448 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 31
Study 34747336 — intervention group
Group type: EXPERIMENTAL
Intervention: Indoor plants
Number of subjects: 60
Study 34747336 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided meditation
Number of subjects: 60
Study 34747336 — intervention group
Group type: COMPARATOR
Intervention: Control rest‐break
Number of subjects: 60
Study 34555671 — intervention group
Group type: EXPERIMENTAL
Intervention: Rocktape plus exercise
Number of subjects: 36
Study 34555671 — intervention group
Group type: COMPARATOR
Intervention: Sham taping plus exercise
Number of subjects: 36
Study 35724842 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth only (phone text messaging and digital self-weighing)
Number of subjects: 0
Study 35724842 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth intervention plus CHW behavioral phone counseling (mHealth+CHW)
Number of subjects: 0
Study 35724842 — intervention group
Group type: COMPARATOR
Intervention: Assessment only
Number of subjects: 0
Study 34932433 — intervention group
Group type: EXPERIMENTAL
Intervention: Restricted Group (sleeping in a supine position)
Number of subjects: 0
Study 34932433 — intervention group
Group type: COMPARATOR
Intervention: Unrestricted Group (no restriction on sleeping position)
Number of subjects: 0
Study 34932433 — intervention group
Group type: COMPARATOR
Intervention: Unrestricted Group
Number of subjects: 0
Study 34932433 — intervention group
Group type: EXPERIMENTAL
Intervention: Restricted Group
Number of subjects: 0
Study 32066284 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride
Number of subjects: 0
Study 32066284 — intervention group
Group type: EXPERIMENTAL
Intervention: Minoxidil
Number of subjects: 0
Study 32066284 — intervention group
Group type: EXPERIMENTAL
Intervention: PRP (platelet-rich plasma)
Number of subjects: 0
Study 34092633 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidomain intervention (n=164)
Number of subjects: 327
Study 34092633 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control group, n=164)
Number of subjects: 327
Study 32619209 — intervention group
Group type: EXPERIMENTAL
Intervention: Motorcycle riding behavior questionnaire (MRBQ)
Number of subjects: 340
Study 32619209 — intervention group
Group type: EXPERIMENTAL
Intervention: Independent predictors of risky riding score
Number of subjects: 340
Study 35250440 — intervention group
Group type: EXPERIMENTAL
Intervention: 1‐Octen‐3‐ol (familiar neutral odor)
Number of subjects: 23
Study 35250440 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyridine
Number of subjects: 23
Study 35250440 — intervention group
Group type: COMPARATOR
Intervention: Water (odorless stimulus)
Number of subjects: 23
Study 35250440 — intervention group
Group type: EXPERIMENTAL
Intervention: 1‐Octen‐3‐ol
Number of subjects: 23
Study 35250440 — intervention group
Group type: EXPERIMENTAL
Intervention: 1‐Octen‐3‐ol and Pyridine
Number of subjects: 23
Study 35250440 — intervention group
Group type: EXPERIMENTAL
Intervention: Olfactory behavioral response
Number of subjects: 23
Study 32249306 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural Language Processing (NLP) analysis on pain-related abstracts
Number of subjects: 200000
Study 32249306 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep learning-based gated recurrent units abstract generation model
Number of subjects: 200000
Study 35876511 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 fiber laser vaporization
Number of subjects: 0
Study 35876511 — intervention group
Group type: COMPARATOR
Intervention: Cystectomy
Number of subjects: 0
Study 33144331 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg [14C]lemborexant (100 µCi)
Number of subjects: 0
Study 32725642 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention for sleep disorders in dementia
Number of subjects: 62
Study 32725642 — intervention group
Group type: EXPERIMENTAL
Intervention: Delphi consensus process
Number of subjects: 62
Study 32725642 — intervention group
Group type: EXPERIMENTAL
Intervention: Distribution-based values
Number of subjects: 62
Study 32725642 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation with DEMQOL-Proxy
Number of subjects: 62
Study 34092191 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-alanine (6.4 g·day‐1 for 28 days)
Number of subjects: 17
Study 34092191 — intervention group
Group type: COMPARATOR
Intervention: Placebo (maltodextrin)
Number of subjects: 17
Study 34092191 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-alanine
Number of subjects: 17
Study 34092191 — intervention group
Group type: COMPARATOR
Intervention: Beta-alanine and Placebo
Number of subjects: 17
Study 32474744 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronate
Number of subjects: 756
Study 32474744 — intervention group
Group type: COMPARATOR
Intervention: Denosumab
Number of subjects: 756
Study 34184418 — intervention group
Group type: EXPERIMENTAL
Intervention: LY01008
Number of subjects: 649
Study 34184418 — intervention group
Group type: COMPARATOR
Intervention: Avastin
Number of subjects: 649
Study 34184418 — intervention group
Group type: EXPERIMENTAL
Intervention: LY01008 and Avastin
Number of subjects: 649
Study 35584890 — intervention group
Group type: EXPERIMENTAL
Intervention: Salutogenic Model-Based Frailty Prevention Program (SAFRAPP)
Number of subjects: 84
Study 35584890 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 84
Study 34868479 — intervention group
Group type: COMPARATOR
Intervention: Unguided online cognitive-behavioral therapy (CBT)
Number of subjects: 0
Study 34868479 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided online cognitive-behavioral therapy (CBT)
Number of subjects: 0
Study 33528893 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ) 400 mg/day for 13 weeks
Number of subjects: 100
Study 33528893 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 35457330 — intervention group
Group type: EXPERIMENTAL
Intervention: L-arginine (8 gr daily for 8 days)
Number of subjects: 15
Study 35457330 — intervention group
Group type: EXPERIMENTAL
Intervention: L-citrulline (8 gr daily for 8 days)
Number of subjects: 15
Study 35457330 — intervention group
Group type: COMPARATOR
Intervention: Placebo (8 gr daily for 8 days)
Number of subjects: 15
Study 35457330 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (L-arginine, L-citrulline, and placebo)
Number of subjects: 15
Study 33337956 — intervention group
Group type: EXPERIMENTAL
Intervention: Flywheel inertia at 0.029 kg·m2
Number of subjects: 15
Study 33337956 — intervention group
Group type: EXPERIMENTAL
Intervention: Flywheel inertia at 0.061 kg·m2
Number of subjects: 15
Study 33337956 — intervention group
Group type: EXPERIMENTAL
Intervention: Flywheel inertia at 0.089 kg·m2
Number of subjects: 15
Study 33337956 — intervention group
Group type: EXPERIMENTAL
Intervention: Flywheel inertia at 0.121 kg·m2
Number of subjects: 15
Study 33337956 — intervention group
Group type: EXPERIMENTAL
Intervention: Flywheel inertia
Number of subjects: 15
Study 32320566 — intervention group
Group type: EXPERIMENTAL
Intervention: Ruxolitinib (10 mg twice daily)
Number of subjects: 309
Study 32320566 — intervention group
Group type: COMPARATOR
Intervention: Control (investigator's choice of therapy)
Number of subjects: 309
Study 33278856 — intervention group
Group type: EXPERIMENTAL
Intervention: pMDI
Number of subjects: 180
Study 33278856 — intervention group
Group type: EXPERIMENTAL
Intervention: Diskus
Number of subjects: 180
Study 33278856 — intervention group
Group type: EXPERIMENTAL
Intervention: Turbohaler
Number of subjects: 180
Study 33278856 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerolizer
Number of subjects: 180
Study 33278856 — intervention group
Group type: EXPERIMENTAL
Intervention: Handihaler
Number of subjects: 180
Study 33278856 — intervention group
Group type: EXPERIMENTAL
Intervention: Breezhaler
Number of subjects: 180
Study 32342438 — intervention group
Group type: EXPERIMENTAL
Intervention: Cessation advising by health care practitioners
Number of subjects: 0
Study 32342438 — intervention group
Group type: COMPARATOR
Intervention: No advising (control group)
Number of subjects: 0